Navigation Links
ARKRAY's GLUCOCARD® Vital and 01 Blood Glucose Meters are now on the Department of Defense Uniform Formulary.
Date:10/28/2011

EDINA, Minn., Oct. 28, 2011 /PRNewswire/ -- ARKRAY USA, Inc. (ARKRAY) announced today that the GLUCOCARD® Vital and 01 are now listed on the Department of Defense (DoD) Uniform Formulary.  The DoD Pharmacy and Therapeutic committee (P&T) selected both the GLUCOCARD® Vital and the GLUCOCARD® 01 Blood Glucose Meters as the first and second most cost effective blood glucose meters in all points of service as noted by the Uniform Formulary Beneficiary Advisory Panel (BAP) earlier this year.

Both GLUCOCARD Vital and GLUCOCARD 01 meter systems feature advanced auto coding technology and require only a tiny sample size at a cost that is less than other blood glucose meter systems on the Uniform Formulary including the current blood glucose meter offered on the Basic Core Formulary.  

"We're excited that ARKRAY has two meters on the Department of Defense Uniform Formulary," said Jonathan Chapman, President of ARKRAY. "Our GLUCOCARD meter systems offer high performance standards.  To be recognized by the DoD for having the most cost-effective blood glucose meters is an honor."

GLUCOCARD meters work with ARK Care™, a Real-Time Diabetes Data Management System.  This unique, patient focused, online software for diabetes management allows patients, healthcare providers and care givers to capture data, see results, and manage ones diabetes. Every GLUCOCARD meter is backed by our GLUCOCARD YouChoose® Wellness and Support Program. Exclusively for GLUCOCARD patients, the program provides free education and support materials, recipes, meal planners, ongoing support, and more.  

ARKRAY will be demonstrating their GLUCOCARD Blood Glucose Meters at the Joint Forces Pharmacy Seminar (JFPS) in Dallas, TX next week.  "Exhibiting at the largest annual event for the military pharmacy community is the perfect opportunity to show pharmacists and technicians first hand how our products perform for their p
'/>"/>

SOURCE ARKRAY USA, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial
2. BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®
3. SAIC Completes Acquisition of Vitalize Consulting Solutions, Inc.
4. ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
5. Recall of Infant and Neonatal-Sized FilterLine H Set and VitaLine H Set Sampling Lines
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Vitalitec Acquires ENCLOSE II Anastomosis Assist Device
8. Dr. F. Stockmans, One of the Earliest Proponents of Materialises Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010
9. FUJIFILM Revitalizes Images of Health Breast Cancer Awareness Initiative
10. Honoring Those Who Collect Blood, Medicines Most Vital Natural Resource
11. Detailed Cholesterol Test Provides Vital Clues for Women in Search of PCOS Answers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Boston Scientific Corporation (NYSE: ... 36 th Annual Global Healthcare Conference on June 9 ... Dan Brennan , executive vice president and chief ... Relations, will participate in a 35-minute question and answer session ... 10 a.m. PT. A live webcast of the ...
(Date:5/26/2015)... 2015 Xencor, Inc. (NASDAQ: XNCR ), ... the treatment of autoimmune diseases, asthma and allergic diseases, ... President and Chief Executive Officer, will present at the ... at 8:30 a.m. ET in New York ... of the presentation will be available on the "Events ...
(Date:5/26/2015)... 26, 2015  Northstar Global Business Services, Inc. ... a deal with Mr. Checkout, a national distribution ... product, SNORenz to brick and mortar retail stores. ... cross section of about fifty convenience stores, pharmacies, ... valuable statistics during the lead time the company ...
Breaking Medicine Technology:Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2Xencor to Present at Jefferies 2015 Healthcare Conference 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 3
... Nev., June 6, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... for: The 2.00% Convertible Senior Notes due February ... 2.875% Convertible Senior Notes due February 15, 2015 (the 2015 Notes), ... due May 1, 2015 (the May 2015 Notes), effective June 6, ...
... 2011 Sanofi (EURONEXT: SAN and NYSE: ... REGN ) today announced that data showing that the ... significantly improved survival in previously treated metastatic colorectal cancer ... on Gastrointestinal Cancer on June 25, 2011.  The abstract ...
Cached Medicine Technology:PDL BioPharma Announces Conversion Rate Adjustments for its Convertible Notes 2ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 2ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 3ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 4ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 5ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 6ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 7
(Date:5/26/2015)... San Diego, CA (PRWEB) May 26, 2015 ... medical director, launched and directed a hospital-wide Patient Blood ... in Bangor that reduced overall blood usage by more ... five-year period. , Covered in detail in an ... PBM program resulted in substantially reduced perioperative red cell ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
(Date:5/26/2015)... Relias Learning , the leader in online ... services market, announces expansion of their user group sessions ... participation in 2014, they will double the number of ... an exciting new facelift. , Regional user group ... best practices, share their expertise, provide feedback directly to ...
(Date:5/26/2015)... 26, 2015 CIO Review has chosen ... Pharma and Life Sciences Technology Solution Providers. The positioning is ... compliant solution which is applicable across the entire security spectrum ... for broad adoption. , “SIGNiX has been on our ... Pharma and Life Sciences Technology space, and we are happy ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... , CRANBURY, N.J., Sept. 10 Amicus ... and chief executive officer, John F. Crowley, will be presenting at the ... scheduled to begin on Monday, September 14 at 5:05 p.m. EDT. , ... the presentation by logging on to the Investors section of the Amicus ...
... Sept. 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... global life sciences markets, today reported financial results for the three-month ... million, a net loss of $62 million and a loss per ... $252 million in total revenue, a net loss of $10 million ...
... , , CAMBRIDGE, ... ISIS ) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ... Office (USPTO) has allowed an Isis patent application that further expands ... patent broadly covers methods of cleaving a target RNA via a ...
... , , , ST. ... ) announced that Novation, the leading health care supply contracting ... systems to its capital products contract portfolio. This is ... robotic interventional technology among Novation,s capital products offerings. This ...
... , SAN DIEGO, Sept. 10 The American ... to educate individuals and couples about their family-building options in a ... 21st. Those who attend Dessert & Learn La Jolla ... Law, about third party reproduction options like egg donation, sperm donation, ...
... (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology ... that disrupt the advance of life-threatening diseases, today announced ... drug target that combats breast cancer. , The target, ... death in breast cancer cells, thus curtailing development of ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2009 Financial Results 2Health News:MDS Reports Third Quarter 2009 Financial Results 3Health News:MDS Reports Third Quarter 2009 Financial Results 4Health News:MDS Reports Third Quarter 2009 Financial Results 5Health News:MDS Reports Third Quarter 2009 Financial Results 6Health News:MDS Reports Third Quarter 2009 Financial Results 7Health News:MDS Reports Third Quarter 2009 Financial Results 8Health News:MDS Reports Third Quarter 2009 Financial Results 9Health News:MDS Reports Third Quarter 2009 Financial Results 10Health News:MDS Reports Third Quarter 2009 Financial Results 11Health News:MDS Reports Third Quarter 2009 Financial Results 12Health News:MDS Reports Third Quarter 2009 Financial Results 13Health News:MDS Reports Third Quarter 2009 Financial Results 14Health News:MDS Reports Third Quarter 2009 Financial Results 15Health News:MDS Reports Third Quarter 2009 Financial Results 16Health News:MDS Reports Third Quarter 2009 Financial Results 17Health News:MDS Reports Third Quarter 2009 Financial Results 18Health News:MDS Reports Third Quarter 2009 Financial Results 19Health News:MDS Reports Third Quarter 2009 Financial Results 20Health News:MDS Reports Third Quarter 2009 Financial Results 21Health News:MDS Reports Third Quarter 2009 Financial Results 22Health News:MDS Reports Third Quarter 2009 Financial Results 23Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 2Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 3Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 4Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 5Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 6Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 2Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 3Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 4Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 2Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 3Health News:GENova files patent for new breast cancer treatment 2
Inquire...
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: